Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina

Science of the Total Environment

Volumn 437, Issue , 2012, Pages 1-9

  Hedgespeth, Melanie Lea ^a   Sapozhnikova, Yelena ^b,e   Pennington, Paul ^b   Clum, Allan ^c   Fairey, Andy ^d   Wirth, Edward ^b  

^a School of Business   (United States)

^b CENTER FOR COASTAL ENVIRONMENTAL HEALTH AND BIOMOLECULAR RESEARCH   (United States)

^c Mount Pleasant Waterworks   (United States)

^d Charleston Water System   (United States)

^e EASTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Effluent; EPA Method 1694; Estuary; Hormone; Influent; Pharmaceutical

Indexed keywords

AQUEOUS CONCENTRATIONS; EFFLUENT CONCENTRATIONS; ENVIRONMENTAL DISTRIBUTION; EPA METHOD; ESTUARINE ECOSYSTEMS; FLUOXETINE; INFLUENT; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; REGIONAL TRENDS; SEASONAL TRENDS; SOUTH ATLANTIC; SOUTH CAROLINA; TREATED WASTEWATER; WASTEWATER EFFLUENTS; WASTEWATER TREATMENT PLANTS; WATER CONCENTRATIONS;

DRUG PRODUCTS; ESTUARIES; HORMONES; SURFACE WATERS; WASTEWATER TREATMENT;

EFFLUENTS;

17ALPHA ESTRADIOL; CAFFEINE; COTININE; DIETHYLSTILBESTROL; EQUILENIN; EQUILIN; ESTRADIOL; ESTRIOL; ESTRONE; ETHINYLESTRADIOL; FLUOXETINE; IBUPROFEN; NORFLUOXETINE; NORGESTREL; PARACETAMOL; PROGESTERONE; SEA WATER; SURFACE WATER; TESTOSTERONE; TRICLOCARBAN; TRICLOSAN;

CONCENTRATION (COMPOSITION); DEGRADATION; DISCHARGE; DRUG; EFFLUENT; ESTUARINE ECOSYSTEM; ESTUARY; HORMONE; SURFACE WATER; WASTEWATER; WATER TREATMENT;

ARTICLE; CONCENTRATION (PARAMETERS); EFFLUENT; ENVIRONMENTAL MONITORING; ESTUARY; GEOGRAPHIC DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; TREND STUDY; UNITED STATES; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER QUALITY; WATER SAMPLING;

NONPRESCRIPTION DRUGS; PHARMACEUTICAL PREPARATIONS; SEASONS; SEAWATER; SOUTH CAROLINA; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER QUALITY;

CHARLESTON HARBOR; SOUTH CAROLINA; UNITED STATES;

EID: 84867593767     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.07.076     Document Type: Article

References (53)

1. Aga D.S. Fate of pharmaceuticals in the environment and in water treatment systems 2008, CRC Press, Boca Raton.
2. Agüera A., Fernández-Alba A.R., Piedra L., Mézcua M., Gómez M.J. Evaluation of triclosan and biphenylol in marine sediments and urban wastewaters by pressurized liquid extraction and solid phase extraction followed by gas chromatography mass spectrometry and liquid chromatography mass spectrometry. Anal Chim Acta 2003, 480(2):193-205.
3. Althausen J.D., Kjerfve B. Distribution of suspended sediment in a partially mixed estuary, Charleston Harbor, South Carolina, U.S.A. Estuar Coast Shelf Sci 1992, 35(5):517-531.
4. Benotti M.J., Brownawell B.J. Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ Sci Technol 2007, 41(16):5795-5802.
5. Benotti M.J., Brownawell B.J. Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ Pollut 2009, 157(3):994-1002.
6. Boyd G.R., Reemtsma H., Grimm D.A., Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 2003, 311(1-3):135-149.
7. Chee-Sanford J.C., Aminov R.I., Krapac I.J., Garrigues-Jeanjean N., Mackie R.I. Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Appl Environ Microb 2001, 67(4):1494-1502.
8. Conley J.M., Symes S.J., Schorr M.S., Richards S.M. Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 2008, 73(8):1178-1187.
9. Daneshvar A., Svanfelt J., Kronberg L., Prévost M., Weyhenmeyer G.A. Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river-lake system. Chemosphere 2010, 80(3):301-309.
10. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
11. de Mes T., Zeeman G., Lettinga G. Occurrence and fate of estrone, 17β-estradiol and 17α-ethynylestradiol in STPs for domestic wastewater. Rev Environ Sci Biotechnol 2005, 4(4):275-311.
12. DeLorenzo M.E., Keller J.M., Arthur C.D., Finnegan M.C., Harper H.E., Winder V.L., et al. Toxicity of the antimicrobial compound triclosan and formation of the metabolite methyl-triclosan in estuarine systems. Environ Toxicol 2008, 23(2):224-232.
13. Dye C., Schlabach M., Green J., Remberger M., Kaj L., Palm-Cousins A., et al. Bronopol, resorcinol, m-cresol and triclosan in the Nordic environment 2007, Nordic Council of Ministers, Copenhagen.
14. Fair P.A., Lee H.-B., Adams J., Darling C., Pacepavicius G., Alaee M., et al. Occurrence of triclosan in plasma of wild Atlantic bottlenose dolphins (Tursiops truncatus) and in their environment. Environ Pollut 2009, 157(8-9):2248-2254.
15. Farré M.l., Pérez S., Kantiani L., Barceló D. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. TrAC Trend Anal Chem 2008, 27(11):991-1007.
16. Gomes R.L., Deacon H.E., Lai K.M., Birkett J.W., Scrimshaw M.D., Lester J.N. An assessment of the bioaccumulation of estrone in Daphnia magna. Environ Toxicol Chem 2004, 23(1):105-108.
17. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36(2):357-393.
18. Heidler J., Halden R.U. Mass balance assessment of triclosan removal during conventional sewage treatment. Chemosphere 2007, 66(2):362-369.
19. Heidler J., Sapkota A., Halden R.U. Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment. Environ Sci Technol 2006, 40(11):3634-3639.
20. Helsel D.R. Less than obvious - statistical treatment of data below the detection limit. Environ Sci Technol 1990, 24(12):1766-1774.
21. Helsel D.R. Nondetects and data analysis: statistics for censored environmental data 2005, John Wiley and Sons, Hoboken, NJ.
22. Huang C.H., Sedlak D.L. Analysis of estrogenic hormones in municipal wastewater effluent and surface water using enzyme-linked immunosorbent assay and gas chromatography/tandem mass spectrometry. Environ Toxicol Chem 2001, 20(1):133-139.
23. Joss A., Andersen H., Ternes T., Richle P.R., Siegrist H. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ Sci Technol 2004, 38(11):3047-3055.
24. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the united states: the slone survey. J Am Med Assoc 2002, 287(3):337-344.
25. Khanal S.K., Xie B., Thompson M.L., Sung S., Ong S.-K., van Leeuwen J. Fate, transport, and biodegradation of natural estrogens in the environment and engineered systems. Environ Sci Technol 2006, 40(21):6537-6546.
26. Kidd K.A., Blanchfield P.J., Mills K.H., Palace V.P., Evans R.E., Lazorchak J.M., et al. Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci 2007, 104(21):8897-8901.
27. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 2007, 41(5):1013-1021.
28. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36(6):1202-1211.
29. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci Technol 2004, 50(5):149-156.
30. Medscape, AHFS Monograph-fluoxetine hydrochloride. November 2010 2010, American Society of Health-System Pharmacists, Inc., http://www.medscape.com/druginfo/monograph?cid=med&drugid=1774.
31. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., Tatarazako N. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 2008, 70(5):865-873.
32. Nash J.P., Kime D.E., Van der Ven L.T.M., Wester P.W., Brion F., Maack G., et al. Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 2004, 112(17):1725-1733.
33. Odum E.P. Basic ecology 1983, CBS College Publishing, Philadelphia, PA.
34. Pait A.S., Warner R.A., Hartwell S.I., Nelson J.O., Pacheco P.A., Mason A.L. Human use pharmaceuticals in the estuarine environment: a survey of the Chesapeake Bay, Biscayne Bay and Gulf of the Farallones 2006, NOAA/NOS/NCCOS/Center for Coastal Monitoring and Assessment, Silver Spring, MD.
35. Radjenovic J., Petrovic M., Barceló D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43(3):831-841.
36. Sapozhnikova Y., Hedgespeth M., Wirth E., Fulton M. Analysis of selected natural and synthetic hormones by LC-MS-MS using the US EPA Method 1694. Anal Methods 2011, 3(5):1079-1086.
37. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ Sci Technol 2010, 44(6):1918-1925.
38. Singh S., Azua A., Chaudhary A., Khan S., Willett K., Gardinali P. Occurrence and distribution of steroids, hormones and selected pharmaceuticals in South Florida coastal environments. Ecotoxicology 2010, 19(2):338-350.
39. Skadsen J.M., Rice B.L., Meyering D.J. The occurrence and fate of pharmaceuticals, personal care products and endocrine disrupting compounds in a municipal water use cycle: a case study in the city of Ann Arbor 2004, City of Ann Arbor Water Utilities, Fleis & VandenBrink Engineering, Inc., Ann Arbor, MI.
40. Suarez S., Carballa M., Omil F., Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?. Rev Environ Sci Biotechnol 2008, 7(2):125-138.
41. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32(11):3245-3260.
42. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci Total Environ 1999, 225(1-2):91-99.
43. Ternes T.A., Stumpf M., Mueller J., Haberer K., Wilken R.D., Servos M. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil. Sci Total Environ 1999, 225(1-2):81-90.
44. Trenholm R.A., Vanderford B.J., Holady J.C., Rexing D.J., Snyder S.A. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 2006, 65(11):1990-1998.
45. USEPA Method 1694: pharmaceuticals and personal care products in water, soil, sediment, and biosolids by HPLC/MS/MS 2007, United States Environmental Protection Agency Office of Water, Washington, DC, EPA 821-R-08-002.
46. USEPA Initial risk-based prioritization of high production volume (HPV) chemicals: triclocarban 2009, United States Environmental Protection Agency, Washington, DC.
47. Vanderford B.J., Snyder S.A. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 2006, 40(23):7312-7320.
48. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal Chem 2003, 75(22):6265-6274.
49. Vethaak A.D., Rijs G.B.J., Schrap S.M., Ruiter H., Gerritsen A., Lahr J. Estrogens and xeno-estrogens in the aquatic environment of the Netherlands: occurrence, potency and biological effects 2002, Dutch National Institute of Inland Water Management and Waste Water Treatment (RIZA), Dutch National Institute for Coastal and Marine Management (RIKZ), the Netherlands.
50. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39(21):8220-8226.
51. Human pharmaceuticals: assessing the impacts on aquatic ecosystems 2005, SETAC Press, Pensacola, FL. R.T. Williams (Ed.).
52. Yu C.P., Roh H., Chu K.H. 17β-Estradiol-degrading bacteria isolated from activated sludge. Environ Sci Technol 2006, 41(2):486-492.
53. Zhou H., Huang X., Wang X., Zhi X., Yang C., Wen X., et al. Behaviour of selected endocrine-disrupting chemicals in three sewage treatment plants of Beijing, China. Environ Monit Assess 2010, 161(1):107-121.